Locations:
Search IconSearch
December 18, 2017/Neurosciences/Research

Deep Brain Stimulation of the Ventral Striatal Area for Post-Stroke Pain Syndrome: An MEG Study

Does the clinical benefit manifest electrophysiologically?

By Raghavan Gopalakrishnan, PhD, and Andre Machado, MD, PhD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Post-stroke pain syndrome (PSPS) is an intractable disorder characterized by unrelenting chronic pain and hemiparesis. While traditional analgesia-based therapeutic approaches (e.g., opioids) have largely failed, integrative approaches targeting affective-cognitive spheres have started to show promise.

Recently, a Cleveland Clinic team demonstrated that deep brain stimulation (DBS) of the ventral striatal area, a key node in the networks that modulate emotion, significantly improved the affective sphere of pain and quality of life in patients with PSPS1 (see coverage of that study here). We subsequently examined whether this observed clinical improvement was reflected in the electrophysiological correlates and whether they could serve as objective biomarkers of affective pain response.

To test this hypothesis, we recorded neural substrates of pain anticipation using magnetoencephalography (MEG), a neuroimaging modality that records magnetic fields produced by neural currents with millisecond precision, in 10 patients with PSPS. Recordings were made preoperatively and postoperatively in the “DBS off” and “DBS on” states. Visual countdown cues (numbered 3, 2 and 1 in triangles in Figure 1 below) evoked anticipation as patients awaited a painful stimulus (PS) or nonpainful stimulus (NPS) to their nonaffected or affected extremity (in separate paradigms). Whole-brain event-related responses, a series of fluctuations in neural currents evoked by anticipatory cues, were examined. The responses have specific functional relevance and are labeled P1, N1, P2, N2, etc., depending on the timing and polarity relative to cue onset.

Advertisement

Figure 1. Magnetoencephalographic neural substrate recordings of pain anticipation in 10 patients with post-stroke pain syndrome before and after deep brain stimulation (DBS). See text for details.

Preoperatively, NPS anticipation was remarkably similar to PS anticipation (as shown in the left portion of Figure 1a), possibly due to loss of salience in a network saturated by pain experience. Postoperatively, DBS significantly modulated the early N1 during NPS anticipation, consistent with networks involving restoration of salience and discrimination capacity (Figure 1a, middle and right). Additionally, DBS suppressed the posterior P2 (aberrant anticipatory anxiety) while enhancing the anterior N1 (cognitive and emotional regulation) in treatment responders (Figure 1b).

We conclude that DBS-induced changes in event-related components reflect treatment effects and could serve as biomarkers for treatment efficacy.

Reference

  1. Lempka SF, Malone DA, Hu B, et al. Randomized clinical trial of deep brain stimulation for poststroke pain. Ann Neurol. 2017;81:653-663.

Dr. Machado (machada@ccf.org) is a neurosurgeon and Chairman of Cleveland Clinic’s Neurological Institute. Dr. Gopalakrishnan (gopalar@ccf.org) is Principal Research Engineer in Cleveland Clinic’s Center for Neurological Restoration. They acknowledge Richard Burgess, MD, PhD, of Cleveland Clinic’s Epilepsy Center, for contributions to the work reported here.

Advertisement

Related Articles

stylized illustration of a chemical compound made up of connected multicolor spheres

What’s the Outlook for BTK Inhibitors in Progressive Multiple Sclerosis?

Despite safety concerns and mixed trial results, experts see potential for this indication

Illustration of two football helmets butting into each other with an inflamed brain underneath one helmet

A Call to Find and Validate Diagnostic Biomarkers for Chronic Traumatic Encephalopathy

Experts endorse a push to improve prevention and treatment following repetitive head injury

dr. charles bernick against decorative background with podcast icon overlay
May 18, 2026/Neurosciences/Podcast

Recognizing and Managing Alzheimer’s Disease in People With Down Syndrome (Podcast)

A population with very high lifetime risk presents care challenges and pathophysiologic insights

Dr. Dylan Wint talking to a patient in a medical office

Alzheimer’s Disease Nears an Inflection Point in Diagnosis and Care

Two Cleveland Clinic neurologists review biomarker advances, targeted therapies and unresolved clinical challenges

brain illustration covered with dots and letter labels atop a ruled grid
May 12, 2026/Neurosciences/Epilepsy

Automated Framework Matches Expert Precision in Mapping Seizure Evolution

Data-driven segmentation approach shows promise for seizure characterization with utility for clinical decision making

Illustration of  a woman's head and a glow where the brain would be

New WAM Grants Support Research on Gut-Brain Interactions, Menopause and Sarcopenia

Alzheimer’s studies delve into preventing and modifying the disease’s trajectory and impact

illustration of lumbar spine with inset showing area of defect
April 23, 2026/Neurosciences/Spine Care

Two-Level Fusion Eases Complex Bertolotti Syndrome Disability

Study finds broadly similar outcomes between MIS and open surgical approaches

Woman helping older woman as she walks with a cane

New Model Performs Well Predicting Parkinson’s Sentinel Falls

System uses clinical data routinely collected at clinical visits

Ad